Bassam Thwainey, MD
Family Medicine · Oak Park, MINPI 1871821389
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 442 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Among family medicine clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 442 payments — averaging $19.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- Boehringer Ingelheim$1K
- GSK$611
- Otsuka America Pharmaceutical, Inc.$601
- Novo Nordisk$586
- AbbVie$458
- plus $4K from 32 others
What the payments were for
- Food & beverage$8,637100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 89 | $1,691 |
| Boehringer Ingelheim | 67 | $1,098 |
| GSK | 32 | $611 |
| Otsuka America Pharmaceutical, Inc. | 17 | $601 |
| Novo Nordisk | 37 | $586 |
| AbbVie(2 entities) | 20 | $458 |
| Amgen(2 entities) | 16 | $378 |
| Exact Sciences | 14 | $369 |
| Bayer | 19 | $364 |
| Pfizer | 21 | $282 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $269 |
| Ironwood Pharmaceuticals, Inc | 13 | $236 |
| Redhill Biopharma Inc. | 9 | $201 |
| Shield Therapeutics Inc | 8 | $163 |
| Axsome Therapeutics, Inc. | 2 | $137 |
| Teva Pharmaceuticals USA, Inc. | 7 | $129 |
| TG Therapeutics, Inc. | 1 | $125 |
| Abbott | 5 | $102 |
| Novartis | 5 | $87 |
| Lilly USA, LLC | 5 | $84 |
| Johnson & Johnson | 6 | $82 |
| Biohaven Pharmaceuticals, Inc. | 5 | $79 |
| Amarin Pharma, Inc. | 3 | $53 |
| Eisai Inc. | 3 | $53 |
| Merck | 4 | $50 |
| Dexcom, Inc. | 3 | $50 |
| Lundbeck LLC | 2 | $39 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Genentech USA, Inc. | 2 | $37 |
| Astellas Pharma US Inc | 2 | $36 |
| Shire North American Group Inc | 1 | $22 |
| Gilead | 1 | $22 |
| Impel Pharmaceuticals Inc. | 1 | $21 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Insulet Corporation | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Dermira, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,637 in reported general payments places this provider in the 95th percentile of 3,945 family medicine providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 92 | $94,050 |
| JardianceEmpagliflozin | 76 | $92,022 |
| FarxigaDapagliflozin Propanediol | 89 | $85,833 |
| OzempicSemaglutide | 70 | $75,663 |
| JanuviaSitagliptin Phosphate | 70 | $71,387 |
| EliquisApixaban | 58 | $52,270 |
| TrulicityDulaglutide | 32 | $32,262 |
| TradjentaLinagliptin | 16 | $18,107 |
| XareltoRivaroxaban | 23 | $17,394 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $14,720 |
| LinzessLinaclotide | 20 | $14,510 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 398 | $9,998 |
| Spiriva HandihalerTiotropium Bromide | 13 | $9,451 |
| MyrbetriqMirabegron | 15 | $8,673 |
| Jentadueto XrLinagliptin/Metformin Hcl | 12 | $7,230 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $84 | $126,312124 claims |
| Boehringer IngelheimJardiance, Tradjenta, Jentadueto Xr | $1,098 | $117,359104 claims |
| AstraZenecaFarxiga, Symbicort | $1,691 | $92,150111 claims |
| Novo NordiskOzempic | $586 | $75,66370 claims |
| MerckJanuvia | $50 | $71,38770 claims |
| PfizerEliquis | $282 | $52,27058 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $611 | $20,91927 claims |
| Johnson & JohnsonXarelto | $82 | $17,39423 claims |
| AbbVieLinzess | $458 | $14,51020 claims |
| Astellas Pharma US IncMyrbetriq | $36 | $8,67315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,945 family medicine providers in Michigan.
Other family medicine in Oak Park
- James VoigtOak Park$140K
- Loren ChudlerSouthfield$1.3M
- Paul BensonBerkley$779K
- Matt RosenbergJackson$550K
- Steve LasaterSaint Johns$291K
- Mary DagenGrand Rapids$265K
- Farhan BhattiLansing$230K
- Jeffrey DeitchSterling Heights$197K
- Sukhpreet SinghPlymouth$173K
- Timothy IzzoGrand Ledge$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.